Form D · Biotechnology
Genia Technologies, Inc.
Mountain View, CA · CIK 0001577527
Offering snapshot reported May 29, 2013 · SEC filing
- Reported sold
- $10.4M Offering amount: $10.4M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- May 15, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 29, 2013 | Initial | $10,438,672 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $200K
- Finders' fees
- $0
- Form D file number
- 021-197134
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Oppenheimer & Co., Inc. | 249 | Oppenheimer & Co., Inc. · CRD 249 |
Source: Form D, filed May 29, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Roger Chen | Director, Executive, Promoter |
| Randall Davis | Director, Executive, Promoter |
| Pratima Rao | Director, Executive, Promoter |
| Stefan Roever | Director, Executive, Promoter |
| Rodney Turner | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
320 Logue Avenue
Mountain View, CA, 94043
Mountain View, CA, 94043